barto nemo (they/them) backupAug 1, 2025

#stwardnienierozsiane

Po 6 latach remisji (wstrzymania) choroby dostałom do kolekcji kolejne dwa ogniska chorobowe, na szczęście nieaktywne, czyli mogłom nawet nie odczuć ich pojawienia się. Może to sprawiły te upały ostatnie :/

No ale tego powodu rozpoczynam kolejny, nowy lek, nowy też w Polsce: Kesimpta (ofatumumab).

Wydaje się spoko, bo zastrzyki będą co miesiąc, a i skutków ubocznych ma ogromnie mniej niż poprzedni lek Tecfidera (codziennie brane kapsułki): obajwy grypo-podobne po zastrzyku (podobnie jak po szczepionkach), czy zakażenie dróg moczowych, oprócz standardowego obniżenia odporności zgodnie z planem leczenia.

#kesimpta #ofatumumab #tecfidera #sm #ms #mswarrior

Silvana NovelliMar 23, 2025
Targeting CD3d is a feasible option after CD20 lost due to #ofatumumab in #CLL in a pts-derived xenograft model ashpublications.org/blood/articl...

Potentiating CD20 monoclonal a...
Bluesky

Bluesky Social
SPC Chemo BotJan 25, 2025
💊💉 #ofatumumab
SmPC for Kesimpta 20 mg solution for injection in pre-filled pen has been updated with changes to sections 4.4 Special warnings and precautions for use; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 10. Date of revision of the text on 30 December 2024.
🌐 https://www.medicines.org.uk/emc/product/12433/smpc
Change log: https://www.medicines.org.uk/emc/product/12433/smpc/history
Kesimpta 20 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc)

Kesimpta 20 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd

SPC Chemo BotJan 24, 2025
💊💉 #ofatumumab
SmPC for Kesimpta 20 mg solution for injection in pre-filled pen has been updated with changes to sections 4.4 Special warnings and precautions for use; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 10. Date of revision of the text on 30 December 2024.
🌐 https://www.medicines.org.uk/emc/product/12433/smpc
Change log: https://www.medicines.org.uk/emc/product/12433/smpc/history
Kesimpta 20 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc)

Kesimpta 20 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd

SPC Chemo BotJan 23, 2025
💊💉 #ofatumumab
SmPC for Kesimpta 20 mg solution for injection in pre-filled pen has been updated with changes to sections 4.4 Special warnings and precautions for use; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 10. Date of revision of the text on 30 December 2024.
🌐 https://www.medicines.org.uk/emc/product/12433/smpc
Change log: https://www.medicines.org.uk/emc/product/12433/smpc/history
Kesimpta 20 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc)

Kesimpta 20 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd

SPC Chemo BotJan 22, 2025
💊💉 #ofatumumab
SmPC for Kesimpta 20 mg solution for injection in pre-filled pen has been updated with changes to sections 4.4 Special warnings and precautions for use; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 10. Date of revision of the text on 30 December 2024.
🌐 https://www.medicines.org.uk/emc/product/12433/smpc
Change log: https://www.medicines.org.uk/emc/product/12433/smpc/history
Kesimpta 20 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc)

Kesimpta 20 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd

SPC Chemo BotJan 21, 2025
💊💉 #ofatumumab
SmPC for Kesimpta 20 mg solution for injection in pre-filled pen has been updated with changes to sections 4.4 Special warnings and precautions for use; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 10. Date of revision of the text on 30 December 2024.
🌐 https://www.medicines.org.uk/emc/product/12433/smpc
Change log: https://www.medicines.org.uk/emc/product/12433/smpc/history
Kesimpta 20 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc)

Kesimpta 20 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd

SPC Chemo BotJan 20, 2025
💊💉 #ofatumumab
SmPC for Kesimpta 20 mg solution for injection in pre-filled pen has been updated with changes to sections 4.4 Special warnings and precautions for use; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 10. Date of revision of the text on 30 December 2024.
🌐 https://www.medicines.org.uk/emc/product/12433/smpc
Change log: https://www.medicines.org.uk/emc/product/12433/smpc/history
Kesimpta 20 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc)

Kesimpta 20 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd

SPC Chemo BotJan 18, 2025
💊💉 #ofatumumab
SmPC for Kesimpta 20 mg solution for injection in pre-filled pen has been updated with changes to sections 4.4 Special warnings and precautions for use; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 10. Date of revision of the text on 30 December 2024.
🌐 https://www.medicines.org.uk/emc/product/12433/smpc
Change log: https://www.medicines.org.uk/emc/product/12433/smpc/history
Kesimpta 20 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc)

Kesimpta 20 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd

SPC Chemo BotJan 17, 2025
💊💉 #ofatumumab
SmPC for Kesimpta 20 mg solution for injection in pre-filled pen has been updated with changes to sections 4.4 Special warnings and precautions for use; 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 10. Date of revision of the text on 30 December 2024.
🌐 https://www.medicines.org.uk/emc/product/12433/smpc
Change log: https://www.medicines.org.uk/emc/product/12433/smpc/history
Kesimpta 20 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc)

Kesimpta 20 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd